A new drug for neutrocytopenia on successful development in Korea.

Dong-A pharmaceutical company (President : Yoo Choong-shik) announced recently that Leucosteam, a new drug for treatment of neutrocytopenia, G-CSF, had been successfully developed for the first time in Korea and the 3rd in the world, by spending 4 billion Won of R&D investment for 6 years from 1992, and highly praised for themselves as saying "it was a wonderful triumph in our bio-engineering r...